Skip to main content
APURES CO., LTD. logo

APURES CO., LTD. — Investor Relations & Filings

Ticker · 149300 ISIN · KR7149300006 KO Professional, scientific and technical activities
Open in API
Filings indexed 196 across all filing types
Latest filing 2025-06-24 Director's Dealing
Country KR South Korea
Listing KO 149300

About APURES CO., LTD.

https://www.apures.com/

APURES CO., LTD. is a biotechnology company specializing in research and development solutions centered on its proprietary "MICROPIG" platform. This internationally registered minipig model, which is anatomically and physiologically similar to humans, serves as a foundation for the company's diverse offerings. APURES develops and supplies standard and transgenic MICROPIG models, along with a portfolio of derived bio-resources including organs, tissues, and standardized primary cells for cell-based assays. The company provides comprehensive non-clinical contract research organization (CRO) services, offering integrated in-vitro and in-vivo testing solutions tailored for new drug development. Additionally, APURES is advancing into therapeutic innovation, developing bio-materials for xenotransplantation and tissue engineering, and pursuing the development of its own pipeline of gene therapies.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean financial authorities. It details the change in share ownership by a director (Choi Sun Duck) of Apures Co., Ltd. due to market sales (disposal). This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company executives.
2025-06-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by major shareholders (specifically (주)메디제네틱스 and related parties) in the company '아퓨어스(주)'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks significant changes in ownership levels.
2025-06-20 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in Korea. It details the sale of shares by a company director (Choi Sun Duck) of Apures Co., Ltd. This type of filing, which reports personal share transactions by company insiders, is classified as 'Director's Dealing' (DIRS).
2025-06-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership by a major shareholder (Medi Genetics Co., Ltd. and related parties) in the company Apures Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-12 Korean
[기재정정]주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Korean Financial Supervisory Service. It details changes in share ownership by major shareholders (Medi Genetics and Choi Seon-deok) in the company Apures (아퓨어스). This type of filing is specifically designed to notify the market when a significant shareholder's stake crosses certain thresholds or changes due to events like collateral liquidation (as noted in the text). In the context of global financial reporting, this falls under 'Major Shareholding Notification'.
2025-06-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/KRX). It details the disposal of shares by a director (Choi Sun Duck) of Apures Co., Ltd. due to the exercise of collateral disposal rights by creditors. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by a company executive.
2025-06-05 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.